Hiromi Sugimoto Selected Research

ramatroban

11/2003	Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats.
4/2003	An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiromi Sugimoto Research Topics

Disease

2	Inflammation (Inflammations) 01/2018 - 07/2004
2	Eosinophilia 11/2003 - 04/2003
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Idiopathic Pulmonary Fibrosis 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Chronic Disease (Chronic Diseases) 12/2011
1	Pneumonia (Pneumonitis) 12/2011
1	Motor Disorders 05/2009
1	Hypersensitivity (Allergy) 02/2008
1	Osteosarcoma (Osteogenic Sarcoma) 12/2005
1	Pain (Aches) 12/2005
1	Atopic Dermatitis (Atopic Eczema) 07/2004
1	Contact Dermatitis (Eczema, Contact) 07/2004
1	Lymphoma (Lymphomas) 11/2003
1	Allergic Rhinitis 04/2003

Drug/Important Bio-Agent (IBA)

2	pirfenidoneIBA 01/2020 - 01/2018
2	ProstaglandinsIBA 07/2004 - 04/2003
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 07/2004 - 11/2003
2	Prostaglandins DIBA 07/2004 - 04/2003
2	ramatrobanIBA 11/2003 - 04/2003
1	CytokinesIBA 01/2020
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2018
1	Extracellular Matrix ProteinsIBA 01/2018
1	CollagenIBA 01/2018
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2018
1	SmokeIBA 12/2011
1	4- ((4- ((((3- Isopropyl- 2- oxo- 2,3- dihydro- 1H- benzimidazol- 1- yl)carbonyl)amino)methyl)piperidin- 1- yl)methyl)tetrahydro- 2H- pyran- 4- carboxylic acidIBA 05/2009
1	Analgesics (Analgesic Drugs)IBA 02/2008
1	N- ((1S)- 1- (aminocarbonyl)- 2,2- dimethylpropyl)- 3- (3- hydroxy- 3- methylbutyl)- 2- oxo- 2,3- dihydro- 1H- benzimidazole- 1- carboxamideIBA 02/2008
1	CannabinoidsIBA 02/2008
1	LigandsIBA 02/2008
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2005
1	Biological ProductsIBA 12/2005
1	Eicosanoid Receptors (Eicosanoid Receptor)IBA 12/2005
1	Cyclic AMP (AMP, Cyclic)IBA 12/2005
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 12/2005
1	Fluorescein-5-isothiocyanate (FITC)IBA 07/2004
1	Chemotactic FactorsIBA 07/2004
1	ChemokinesIBA 07/2004
1	CalciumIBA 11/2003
1	Prostaglandin H2 Thromboxane A2 ReceptorsIBA 11/2003
1	Prostaglandin D2IBA 11/2003
1	AntigensIBA 04/2003
1	ThromboxanesIBA 04/2003

Therapy/Procedure

1	Ligation 07/2004
1	Intranasal Administration 04/2003